The round was led by Hatteras Venture Partners, with participation from OSF Ventures, the venture capital arm of OSF HealthCare, an Illinois-based health system with 124 locations and 13 hospitals, and existing investors including Sovereign’s Capital. In conjunction with the funding, Jeff Terrell, Partner at Hatteras, will be joining the 410 Medical Board of Directors along with Stan Lynall, Vice President of Venture Investments at OSF Ventures.
The company intends to use the funds to expand commercialization of LifeFlow in hospital and pre-hospital environments nationwide.
Founded in 2013 by Kyle Chenet, Chief Executive Officer, 410 Medical is a medical device company dedicated to developing innovative products that enable frontline medical providers to improve care for critically ill patients. Its first product, LifeFlow, is designed to enhance the speed and efficiency of fluid resuscitation, improving care for patients with life-threatening illnesses such as sepsis and shock.
LifeFlow was cleared by the FDA for human use in 2016.
FinSMEs
22/10/2019